Axonis Therapeutics
Biotechnology, 700 Main St North, Cambridge, Massachusetts, 02139, United States, 11-50 Employees
Phone Number: 94********
Who is AXONIS THERAPEUTICS
AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for p...
Read More
-
Headquarters: 700 Main St North, Cambridge, Massachusetts, 02139, United States
-
Date Founded: 2008
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO:
Joanna Stanicka
Email
Phone
Industry: Biotechnology
SIC Code: 8049
|
NAICS Code: 621340 |
Show More
Does something look wrong? Fix it. | View contact records from AXONIS THERAPEUTICS
AXONIS Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding AXONIS Therapeutics
Answer: AXONIS Therapeutics's headquarters are located at 700 Main St North, Cambridge, Massachusetts, 02139, United States
Answer: AXONIS Therapeutics's phone number is 94********
Answer: AXONIS Therapeutics's official website is https://axonis.us
Answer: AXONIS Therapeutics's revenue is $1 Million to $5 Million
Answer: AXONIS Therapeutics's SIC: 8049
Answer: AXONIS Therapeutics's NAICS: 621340
Answer: AXONIS Therapeutics has 11-50 employees
Answer: AXONIS Therapeutics is in Biotechnology
Answer: AXONIS Therapeutics contact info: Phone number: 94******** Website: https://axonis.us
Answer: AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system. Operational since 2020, AXONIS is a seed-stage therapeutics company based in LabCentral, MA, and has assembled a team of world-leading innovators, serial entrepreneurs, successful drug developers, driven scientists and passionate patient advocates. Adult-onset central nervous system (CNS) disorders are an urgent, unmet, global and growing burden, especially as more people are living longer. Neuron degeneration and excitation/inhibition imbalances are fundamental problems of many debilitating neurological disorders. AXONIS is developing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month